BNET Industries
Market Cap:$416.7M
Last Fiscal Year Sales:$97.0M
- Public
- US
Dow Jones Description
SurModics is a leading provider of drug delivery and surface modification technologies to the healthcare industry. In November 2008, we announced a change in our organizational structure into four clinically and market focused business units: Cardiovascular, Ophthalmology, In Vitro Technologies, and SurModics Pharmaceuticals (formerly Brookwood Pharmaceuticals). We believe that this structure will improve the visibility, marketing and adoption of the Companys broad array of technologies within specific markets and help our customers in the medical device, pharmaceutical and life science industries better solve unmet clinical needs. In addition, a new centralized research and development function has been formed to serve the needs of the Companys clinically and market focused business units. SurModics Pharmaceuticals research and development operations remained unchanged. The reorganization change announced in November 2008 resulted in the Company being comprised of new operating segments. ...
Number of Employees 254
Peer Companies
NAICS Code Lessors of Nonfinancial Intangible Assets (except Copyrighted Works): 533110
Recent Events
-
Developments for Parkinson's Disease Ignite Investor Enthusiasm
-
SurModics signs license agreement with NuPathe for long-acting delivery (LADTM) technology
-
Barrington Research Downgrades SurModics SRDX to Market Perform
-
SurModics enters license and development agreement with Roche and Genentech
-
SurModics Enters Ophthalmic License and Development Agreement with Roche and Genentech
-
Genentech inks licensing deal with SurModics
-
SurModics inks $200M licensing deal with Genetech
-
SRDX: License and Development Agreement with Roche and Genentech
-
UPDATE 1-Church & Dwight settles with Abbott Labs, SurModics
-
SurModics Reports Third Quarter 2009 Results
News & Analysis
Filter by
strategy and surmodics inc. - All News and Analysis
SurModics Q2 2009 Earnings Transcript
Seeking Alpha
- 2009-07-30
Question-and-Answer SessionOperator Thank you sir. We will now begin the question-and-answer session. Operator Instructions. And our first question is from Ross Taylor from CL Kings. Please go ahead. Ross Taylor - CL Kings & Associates I have two or three questions. First related to some of the financials, R&D...
SurModics to Present at the 2008 Association for Research in Vision and Ophthalmology Meeting
- 2008-04-24
EDEN PRAIRIE, Minn. -- SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today that two posters and one paper will be presented at the 2008 Association for Research in Vision and Ophthalmology ARVO Meeting being held April 27 -...
VTO, AZL, BPHX, PSDV, SRDX, XTLB Have Been Removed From Naked Short List Today.
- 2007-03-22
M2 PRESSWIRE-22 March 2007-BUYINS.NET: VTO, AZL, BPHX, PSDV, SRDX, XTLB Have Been Removed From Naked Short List TodayC1994-2007 M2 COMMUNICATIONS LTD RDATE:22032007 BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short...
- 1
Glass Door
| Company | Employer Rating |
| Alcoa |  |
| CBS Corp |  |
| Johnson & Johnson | |
| Costco Wholesale |  |
|
IndustryTop Rated
- Google Offers Free Downloads of a Million Books 11 votes
- InsideView Disrupts Legacy Business Info Publishers Like Hoover's 9 votes
- Mobile is the New Mass Medium, For Better or Worse 8 votes
- As Income Mobility Falls, American Dream Fades 7 votes
- Google, OpenDocs, Apple, Others Also in Danger from i4i 6 votes
Presented by American Express